RENABIOTX
Live / Applied — Non-final action mailed (as of 02 Dec 2025)
What this means for you
Not registered yet, but its 27 Jun 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99257087
- Mark type
- Stylized text
- Filed
- 27 Jun 2025
- Attorney of record
- Martin Z. Zhang
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of solid tumor cancer; Pharmaceutical preparations for the delivery of therapeutic agents; Drug delivery systems in the form of nanoparticle for use in human and veterinary medicine; Pharmaceutical preparations for the treatment of hepatocellular carcinoma; Pharmaceutical preparations for the treatment of glioblastoma multiforme
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- RenaBio Therapeutics Inc., Natick, MA, US
Prosecution history
- 02 Mar 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 02 Mar 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 02 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Dec 2025 — NON-FINAL ACTION E-MAILED
- 02 Dec 2025 — NON-FINAL ACTION WRITTEN
- 17 Nov 2025 — ASSIGNED TO EXAMINER
- 28 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 27 Jun 2025 — NEW APPLICATION ENTERED